Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.
about
In vivo activities of newer rifamycin analogs against Mycobacterium avium infectionActivity of clarithromycin against Mycobacterium avium complex infection in beige miceIn vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacinEffect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient miceActivities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse modelEffectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelA bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditionsIn vitro activities of rifabutin, azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, and amikacin in combinations of two, three, and four drugs against Mycobacterium aviumPostantibiotic effect of clarithromycin alone and combined with ethambutol against Mycobacterium avium complexEpidemiology of infection by nontuberculous mycobacteriaPharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.The Mycobacterium avium complexNontuberculous mycobacteria: opportunistic environmental pathogens for predisposed hosts.In vitro susceptibility of Mycobacterium ulcerans to clarithromycinIn vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infection.Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.
P2860
Q28322002-1AC6B763-61E2-415F-844F-B7E4F3B95C17Q28327192-2E9E0ED4-64E1-4ADD-85C3-61244B7FEFEDQ28328860-A5D92008-22A9-4AB7-9481-AAE3FA2BB610Q28330848-0020D587-2E5A-4892-8867-690908FD9085Q28368218-1CB4AFD8-B960-4512-9B1D-0521F1680A7CQ28368450-C615EE32-CDF0-4225-B057-7893858193CEQ28368663-4A0F2533-6312-423D-9E3B-ABA23C62B352Q28379222-73C99765-1390-453B-8283-29163E52D0DAQ35121082-5FF49ED7-5651-4E15-8849-20747283F76FQ35370226-E35A8206-3857-4D11-A722-BAFAE6DF055BQ35806445-CA635093-F1BC-4504-BCB8-C160295489B4Q36156072-0B6ED1B5-9CDC-4895-ADBF-F7719DC696AAQ36640345-BC2CA27E-23EA-4570-805C-399C937438F4Q37803294-6BA8C1BF-FA95-48AA-8F01-430CD6A26689Q39364483-32EF5681-FF70-4B94-A6A5-793313C692DCQ39779350-8ABE6136-094A-42E5-B994-92C883E36F88Q40087100-2C73E527-458A-4609-813D-50DBF2F8DF5BQ40285262-C27AB069-EF0A-4586-AE93-B8986E7F1278
P2860
Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Antimicrobial synergism agains ...... ed immune deficiency syndrome.
@en
Antimicrobial synergism agains ...... ed immune deficiency syndrome.
@nl
type
label
Antimicrobial synergism agains ...... ed immune deficiency syndrome.
@en
Antimicrobial synergism agains ...... ed immune deficiency syndrome.
@nl
prefLabel
Antimicrobial synergism agains ...... ed immune deficiency syndrome.
@en
Antimicrobial synergism agains ...... ed immune deficiency syndrome.
@nl
P2093
P2860
P356
P1476
Antimicrobial synergism agains ...... ed immune deficiency syndrome.
@en
P2093
P2860
P304
P356
10.1128/AAC.32.9.1392
P407
P577
1988-09-01T00:00:00Z